GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Cyclically Adjusted PS Ratio

Diagnos (TSXV:ADK) Cyclically Adjusted PS Ratio : (As of Jan. 19, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Diagnos Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Diagnos Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Diagnos's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Cyclically Adjusted PS Ratio Chart

Diagnos Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.23 3.89 2.04 3.46 3.95

Diagnos Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.61 3.95 - -

Competitive Comparison of Diagnos's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, Diagnos's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnos's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Diagnos's Cyclically Adjusted PS Ratio falls into.



Diagnos Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Diagnos's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 is calculated as:

For example, Diagnos's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0/127.2847*127.2847
=0.000

Current CPI (Sep. 2024) = 127.2847.

Diagnos Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.020 98.367 0.026
201503 0.012 99.789 0.015
201506 0.014 100.500 0.018
201509 0.021 100.421 0.027
201512 0.034 99.947 0.043
201603 0.023 101.054 0.029
201606 0.025 102.002 0.031
201609 0.030 101.765 0.038
201612 0.100 101.449 0.125
201703 0.025 102.634 0.031
201706 0.021 103.029 0.026
201709 0.016 103.345 0.020
201712 0.054 103.345 0.067
201803 0.004 105.004 0.005
201806 0.005 105.557 0.006
201809 0.003 105.636 0.004
201812 0.005 105.399 0.006
201903 0.004 106.979 0.005
201906 0.003 107.690 0.004
201909 0.002 107.611 0.002
201912 0.002 107.769 0.002
202003 0.002 107.927 0.002
202006 0.001 108.401 0.001
202009 0.001 108.164 0.001
202012 0.001 108.559 0.001
202103 0.001 110.298 0.001
202106 0.001 111.720 0.001
202109 0.001 112.905 0.001
202112 0.002 113.774 0.002
202203 0.002 117.646 0.002
202206 0.002 120.806 0.002
202209 0.002 120.648 0.002
202212 0.002 120.964 0.002
202303 0.001 122.702 0.001
202306 0.001 124.203 0.001
202309 0.000 125.230 0.000
202312 0.001 125.072 0.001
202403 0.001 126.258 0.001
202406 0.000 127.522 0.000
202409 0.000 127.285 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Diagnos  (TSXV:ADK) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Diagnos Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Diagnos's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.
Executives
Tristram Coffin 10% Security Holder
Marc-andré Massue Senior Officer
Robert Dunn Director
Francis Bellido Director
Vincent Duhamel Director
André Larente Director, Senior Officer
Guillermo Moreno Robles Senior Officer
Georges Hébert Director
Gestion Maurice Pinsonnault Inc. 10% Security Holder

Diagnos Headlines

No Headlines